NF90 is a novel influenza A virus NS1-interacting protein that antagonizes the inhibitory role of NS1 on PKR phosphorylation

FEBS Letters

Volumn , Issue , 2016, Pages 2797-2810

  Li, Ting ^a   Li, Xi ^a   Zhu, WenFei ^b   Wang, HuiYu ^a   Mei, Lin ^a   Wu, ShaoQiang ^a   Lin, XiangMei ^a   Han, XueQing ^a  

^a CHINESE ACADEMY OF INSPECTION AND QUARANTINE   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

influenza A virus; NF90; nonstructural protein 1; protein kinase R phosphorylation; stress granules

Indexed keywords

INTERLEUKIN ENHANCER BINDING FACTOR 3; NONSTRUCTURAL PROTEIN 1; PROTEIN KINASE R;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; IN VIVO STUDY; INFLUENZA A VIRUS (H7N9); INHIBITION KINETICS; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 84983458210     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12311     Document Type: Article

References (69)

1. Hale BG, Randall RE, Ortin J and Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89 (Pt 10), 2359–2376.
2. Chen Z, Li Y and Krug RM (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3’-end processing machinery. EMBO J 18, 2273–2283.
3. Nemeroff ME, Barabino SM, Li Y, Keller W and Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell 1, 991–1000.
4. Noah DL, Twu KY and Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3’ end processing of cellular pre-mRNAS. Virology 307, 386–395.
5. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F and Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314, 997–1001.
6. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU and Garcia-Sastre A (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439–449.
7. Shin YK, Liu Q, Tikoo SK, Babiuk LA and Zhou Y (2007) Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88 (Pt 1), 13–18.
8. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M and Ludwig S (2007) Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81, 3058–3067.
9. Hale BG, Jackson D, Chen YH, Lamb RA and Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 103, 14194–14199.
10. Aragon T, de la Luna S, Novoa I, Carrasco L, Ortin J and Nieto A (2000) Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20, 6259–6268.
11. Burgui I, Aragon T, Ortin J and Nieto A (2003) PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 84 (Pt 12), 3263–3274.
12. Min JY and Krug RM (2006) The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2’-5’ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci USA 103, 7100–7105.
13. Lu Y, Wambach M, Katze MG and Krug RM (1995) Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222–228.
14. Hatada E, Saito S and Fukuda R (1999) Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 73, 2425–2433.
15. Galabru J and Hovanessian A (1987) Autophosphorylation of the protein kinase dependent on double-stranded RNA. J Biol Chem 262, 15538–15544.
16. Patel RC and Sen GC (1998) PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 17, 4379–4390.
17. Hershey JW (1991) Translational control in mammalian cells. Annu Rev Biochem 60, 717–755.
18. Lloyd RE (2013) Regulation of stress granules and P-bodies during RNA virus infection. Wiley Interdiscip Rev RNA 4, 317–331.
19. Tsai WC and Lloyd RE (2014) Cytoplasmic RNA granules and viral infection. Annu Rev Virol 1, 147–170.
20. Buchan JR and Parker R (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36, 932–941.
21. Kumar A, Haque J, Lacoste J, Hiscott J and Williams BR (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA 91, 6288–6292.
22. Katze MG, Detjen BM, Safer B and Krug RM (1986) Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol 6, 1741–1750.
23. Tan SL and Katze MG (1998) Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 18, 757–766.
24. Li S, Min JY, Krug RM and Sen GC (2006) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349, 13–21.
25. Min JY, Li S, Sen GC and Krug RM (2007) A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363, 236–243.
26. Li F, Chen Y, Zhang Z, Ouyang J, Wang Y, Yan R, Huang S, Gao GF, Guo G and Chen JL (2015) Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity. Nucleic Acids Res 43, 10321–10337.
27. Mok BW, Song W, Wang P, Tai H, Chen Y, Zheng M, Wen X, Lau SY, Wu WL and Matsumoto K (2012) The NS1 protein of influenza A virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. J Virol 86, 12695–12707.
28. Khaperskyy DA, Hatchette TF and McCormick C (2012) Influenza A virus inhibits cytoplasmic stress granule formation. FASEB J 26, 1629–1639.
29. Saunders LR, Perkins DJ, Balachandran S, Michaels R, Ford R, Mayeda A and Barber GN (2001) Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. J Biol Chem 276, 32300–32312.
30. Patel RC, Vestal DJ, Xu Z, Bandyopadhyay S, Guo W, Erme SM, Williams BR and Sen GC (1999) DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J Biol Chem 274, 20432–20437.
31. Parker LM, Fierro-Monti I and Mathews MB (2001) Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J Biol Chem 276, 32522–32530.
32. Pfeifer I, Elsby R, Fernandez M, Faria PA, Nussenzveig DR, Lossos IS, Fontoura BM, Martin WD and Barber GN (2008) NFAR-1 and -2 modulate translation and are required for efficient host defense. Proc Natl Acad Sci USA 105, 4173–4178.
33. Langland JO, Kao PN and Jacobs BL (1999) Nuclear factor-90 of activated T-cells: a double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry 38, 6361–6368.
34. Durand DB, Shaw JP, Bush MR, Replogle RE, Belagaje R and Crabtree GR (1988) Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol 8, 1715–1724.
35. Kao PN, Chen L, Brock G, Ng J, Kenny J, Smith AJ and Corthesy B (1994) Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J Biol Chem 269, 20691–20699.
36. Shi L, Godfrey WR, Lin J, Zhao G and Kao PN (2007) NF90 regulates inducible IL-2 gene expression in T cells. J Exp Med 204, 971–977.
37. Shim J, Lim H, Yates JR and Karin M (2002) Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol Cell 10, 1331–1344.
38. Harashima A, Guettouche T and Barber GN (2010) Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase PKR constitutes a novel mechanism of translational regulation and cellular defense. Genes Dev 24, 2640–2653.
39. Patino C, Haenni AL and Urcuqui-Inchima S (2015) NF90 isoforms, a new family of cellular proteins involved in viral replication? Biochimie 108, 20–24.
40. Wang P, Song W, Mok BW, Zhao P, Qin K, Lai A, Smith GJ, Zhang J, Lin T and Guan Y (2009) Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein. J Virol 83, 7850–7861.
41. Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK and Basler CF (2011) DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J Infect Dis 204 (Suppl 3), S911–S918.
42. Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC 3rd and Kumar A (2007) Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1. Retrovirology 4, 41.
43. Hoque M, Shamanna RA, Guan D, Pe'ery T and Mathews MB (2011) HIV-1 replication and latency are regulated by translational control of cyclin T1. J Mol Biol 410, 917–932.
44. Merrill MK, Dobrikova EY and Gromeier M (2006) Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76. J Virol 80, 3147–3156.
45. Merrill MK and Gromeier M (2006) The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J Virol 80, 6936–6942.
46. Gomila RC, Martin GW and Gehrke L (2011) NF90 binds the dengue virus RNA 3’ terminus and is a positive regulator of dengue virus replication. PLoS One 6, e16687.
47. Li Y and Belshan M (2016) NF45 and NF90 bind HIV-1 RNA and modulate HIV gene expression. Viruses 8, 47.
48. Shin HJ, Kim SS, Cho YH, Lee SG and Rho HM (2002) Host cell proteins binding to the encapsidation signal epsilon in hepatitis B virus RNA. Arch Virol 147, 471–491.
49. Isken O, Baroth M, Grassmann CW, Weinlich S, Ostareck DH, Ostareck-Lederer A and Behrens SE (2007) Nuclear factors are involved in hepatitis C virus RNA replication. RNA 13, 1675–1692.
50. Li Y, Masaki T, Shimakami T and Lemon SM (2014) hnRNP L and NF90 interact with hepatitis C virus 5’-terminal untranslated RNA and promote efficient replication. J Virol 88, 7199–7209.
51. Shamanna RA, Hoque M, Pe'ery T and Mathews MB (2013) Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells. Oncogene 32, 5176–5185.
52. Wen X, Huang X, Mok BW, Chen Y, Zheng M, Lau SY, Wang P, Song W, Jin DY and Yuen KY (2014) NF90 exerts antiviral activity through regulation of PKR phosphorylation and stress granules in infected cells. J Immunol 192, 3753–3764.
53. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT and Krug RM (1999) RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5, 195–205.
54. Donelan NR, Basler CF and Garcia-Sastre A (2003) A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77, 13257–13266.
55. Parker LM, Fierro-Monti I, Reichman TW, Gunnery S and Mathews MB (2001) Double-stranded RNA-binding proteins and the control of protein synthesis and cell growth. Cold Spring Harb Symp Quant Biol 66, 485–497.
56. Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S and Nagata K (2012) Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7, e43031.
57. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR and Hovanessian AG (1990) Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379–390.
58. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR and Barber GN (2000) Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129–141.
59. Pindel A and Sadler A (2011) The role of protein kinase R in the interferon response. J Interferon Cytokine Res 31, 59–70.
60. Gale M Jr and Katze MG (1998) Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78, 29–46.
61. Winterling C, Koch M, Koeppel M, Garcia-Alcalde F, Karlas A and Meyer TF (2014) Evidence for a crucial role of a host non-coding RNA in influenza A virus replication. RNA Biol 11, 66–75.
62. Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, Carnero E, Barriocanal M, Fortes P and Anthony DD (2014) Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res 42, 10668–10680.
63. Ouyang J, Zhu X, Chen Y, Wei H, Chen Q, Chi X, Qi B, Zhang L, Zhao Y and Gao GF (2014) NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription. Cell Host Microbe 16, 616–626.
64. Gottwein E and Cullen BR (2008) Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3, 375–387.
65. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P and Muster T (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74, 6203–6206.
66. Bornholdt ZA and Prasad BV (2008) X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature 456, 985–988.
67. Okonski KM and Samuel CE (2013) Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1. J Virol 87, 756–766.
68. White JP and Lloyd RE (2012) Regulation of stress granules in virus systems. Trends Microbiol 20, 175–183.
69. Jian SF, Hsiao CC, Chen SY, Weng CC, Kuo TL, Wu DC, Hung WC and Cheng KH (2014) Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/beta-catenin pathway of lung cancer cells. Mol Cancer Res 12, 622–635.